- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00792961
Real Time Microscopic Imaging During Robot Assisted Prostate Cancer Surgery
April 7, 2014 updated by: Peter Delaney
In Vivo Confocal Endomicroscopy During da Vinci Robot Assisted Prostatectomy: Feasibility Study
The study involves use of a device called an endomicroscope to obtain high resolution images of microscopic structures during robot-assisted prostate cancer surgery.
This feasibility study is largely descriptive, and will use endomicroscopy to document the cellular and architectural appearance of tissue during minimally invasive prostate surgery for later comparison with features seen upon conventional histopathological examination of biopsies or resection specimens.
Study Overview
Detailed Description
Prostate surgery requires meticulous dissection around nerves and associated structures such as the bladder, seminal vesicles and vas deferens.
Nerve damage during prostatectomy can result in undesirable outcomes such as impotence and urinary incontinence.
Robot assisted minimally invasive prostatectomy offers enhanced visualisation of the surgical field.
Superior clinical outcomes in terms of length of hospital stay, blood loss, and oncologic margins compared with open surgery are reported.
Confocal endomicroscopy provides high resolution subsurface cellular imaging in real time and is already in clinical use in gastroenterology and under investigation in other surgical applications.
A potential role exists for confocal endomicroscopy to enhance microscopic nerve identification intra-operatively and guide surgical decision making during robot-assisted prostatectomy.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Austin, Texas, United States, 78746
- The Hospital at Westlake Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Males diagnosed with prostate cancer and undergoing da Vinci radical prostatectomy
Exclusion Criteria:
- Patients under 18 years of age
- Patients with allergy or prior adverse reaction to Fluorescein Sodium
- Patients unable to give informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Endomicroscopy
Endomicroscopy is performed in addition to the patient's indicated robot-assisted prostate surgery
|
Rigid drop-in endomicroscope imaging probe
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Endomicroscopy images captured from prostate and surrounding tissues
Time Frame: During surgery
|
During surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Comparison with conventional histology from corresponding biopsies or resection specimens
Time Frame: Post-surgery, after pathologist's review
|
Post-surgery, after pathologist's review
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Randy Fagin, MD, The Hospital at Westlake Medical Center
- Study Director: Peter Delaney, BSc, Optiscan Pty Ltd
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2008
Primary Completion (ACTUAL)
December 1, 2009
Study Completion (ACTUAL)
December 1, 2009
Study Registration Dates
First Submitted
November 16, 2008
First Submitted That Met QC Criteria
November 16, 2008
First Posted (ESTIMATE)
November 18, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
April 9, 2014
Last Update Submitted That Met QC Criteria
April 7, 2014
Last Verified
April 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13082008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.